NCT05049187View on ClinicalTrials.gov

Characterization and Durability of COVID-19 Vaccine Induced Immune Responses in Healthcare/Frontline Workers

CompletedOBSERVATIONAL

Enrollment

132

Participants

Timeline

Start Date

May 7, 2021

Primary Completion Date

March 1, 2023

Study Completion Date

March 1, 2023

Conditions

Covid19

Trial Locations (1)

600031

National Institute for Research in Tuberculosis, Chennai

All Listed Sponsors

collaborator

National Institute of Epidemiology

UNKNOWN

lead

Tuberculosis Research Centre, India

OTHER_GOV